Pace and Red Ginger Make Efficient TB Treatment

Indonesia is the country with the fourth largest number of TB sufferers in the world. Therefore, the required TB treatment methods that are more efficient in order to improve the condition. One of the methods that make the treatment of TB is becoming more powerful and fast is the pace and Red ginger extract.

Pulmonary specialist from RS Friendship Jakarta Arifin Nawas said random clinics, test on a patient's TB shows, a combination of noni extract and Red ginger can make TB treatment more efficient. "The treatment becomes faster and stronger," he said.

In discussions of SOHO #BetterU entitled World Tuberculosis Day in Jakarta, Wednesday (3/19/2014), Arifin explained, a combination of pace and Red Ginger is not a primary treatment of TB, but rather as complementary or adjunctive treatment of TB.

Both of these herbs have different roles in the treatment of TB. Arifin explained, mengkudu extract can activate the immune system of the patient. "The new TB disease is known to occur after infected with the TB bacterium because the immune system of the body that is declining," he said.

Meanwhile, a combination of pace and Red ginger gives the effect of antimicrobial synergy that prevent bacteria from TB to grow and proliferate. That's why the combination can also help reduce the transmission of TB.

Arifin said, in less or equal to six the total of 20 patients group, a combination of pace and ginger have improved conditions compared with 13 patients were only given a placebo. The parameters used are the changes of acid-resistant Bacilli (BTA) positive to negative the BTA.

The research was carried out on 100 patients who were divided into two groups, namely the groups given the treatment of TB and the combination of noni extract and Red ginger, and the group that was given a placebo and TB treatment.

"The combination of noni extract and Ginger can be given as an adjunct in patients undergoing TB treatment TB national TB guidelines, appropriate" advice Arifin.

Kendari, Arifin said, further research is needed with larger numbers of subjects and examination more complete immunological status.